The phenotype of SCN8A developmental and epileptic encephalopathy
Authors:
- Elena GardellaEGElena Gardella
- Carla MariniCMCarla Marini
- Marina TrivisanoMTMarina Trivisano
- Mark P. FitzgeraldMFMark P. Fitzgerald
- Michael AlberMAMichael Alber
- Katherine B. HowellKHKatherine B. Howell
- Francesca DarraFDFrancesca Darra
- Sabrina SiliquiniSSSabrina Siliquini
- Bigna K. BölsterliBBBigna K. Bölsterli
- Silva MasnadaSMSilva Masnada
- Anna PichiecchioAPAnna Pichiecchio
- Katrine M. JohannesenKJKatrine M. Johannesen
- 18 September 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 91 (12) , e1112-e1124
Abstract
Objective To delineate the electroclinical features of SCN8A infantile developmental and epileptic encephalopathy (EIEE13, OMIM #614558). Methods Twenty-two patients, aged 19 months to 22 years, underwent electroclinical assessment. Results Sixteen of 22 patients had mildly delayed development since birth. Drug-resistant epilepsy started at a median age of 4 months, followed by developmental slowing, pyramidal/extrapyramidal signs (22/22), movement disorders (12/22), cortical blindness (17/22), sialorrhea, and severe gastrointestinal symptoms (15/22), worsening during early childhood and plateauing at age 5 to 9 years. Death occurred in 4 children, following extreme neurologic deterioration, at 22 months to 5.5 years. Nonconvulsive status epilepticus recurred in 14 of 22 patients. The most effective antiepileptic drugs were oxcarbazepine, carbamazepine, phenytoin, and benzodiazepines. EEG showed background deterioration, epileptiform abnormalities with a temporo-occipital predominance, and posterior delta/beta activity correlating with visual impairment. Video-EEG documented focal seizures (FS) (22/22), spasm-like episodes (8/22), cortical myoclonus (8/22), and myoclonic absences (1/22). FS typically clustered and were prolonged (SCN8A developmental and epileptic encephalopathy has strikingly consistent electroclinical features, suggesting a global progressive brain dysfunction primarily affecting the temporo-occipital regions. Both uncontrolled epilepsy and developmental compromise contribute to the profound impairment (increasing risk of death) during early childhood, but stabilization occurs in late childhood.Keywords
This publication has 34 references indexed in Scilit:
- De novo mutations in epileptic encephalopathiesNature, 2013
- Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disabilityFrontiers in Genetics, 2013
- De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEPThe American Journal of Human Genetics, 2012
- KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathyAnnals of Neurology, 2011
- Nonpharmacologic treatments of Dravet syndrome: Focus on the ketogenic dietEpilepsia, 2011
- Electroencephalographic characteristics of Dravet syndromeEpilepsia, 2011
- Dysfunction of the Scn8a Voltage-gated Sodium Channel Alters Sleep Architecture, Reduces Diurnal Corticosterone Levels, and Enhances Spatial MemoryJournal of Biological Chemistry, 2010
- Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in miceHuman Molecular Genetics, 2009
- Visual Function in Infants with West Syndrome: Correlation with EEG PatternsEpilepsia, 2004
- Visual function and EEG reactivity in infants with perinatal brain lesions at 1 yearDevelopmental Medicine & Child Neurology, 2002